Skip to content
Sign up to receive our free weekday morning edition, and you'll never miss a scoop.
The top four congressional leaders traded accusations about the existence — or lack thereof — of a formal offer to end the government shutdown.

Deal or no deal? Nothing happening, leaders say

The top four congressional leaders spent Thursday trading accusations about the existence — or lack thereof — of a formal offer to end the government shutdown, now in its 16th day.

The high-level back-and-forth shows that each side — facing growing pressure to do something as the shutdown grinds on — is still more intent on blaming the opposition for the stalemate than finding a solution.

Subscripion logo

You're seeing a preview of our Premium coverage. Read the full story by subscribing here.

Presented by AstraZeneca

The 340B program was created to help patients. Instead, it’s helping hospitals earn massive profits. The 340B Rebate Model Pilot uses rapid verification of existing data to prevent duplicate discounts, strengthening program transparency and efficiency. Urge HHS to implement the Rebate Model Pilot and ensure 340B functions as intended. Get the facts.

Editorial photos provided by Getty Images. Political ads courtesy of AdImpact.

Presented by AstraZeneca

The 340B program is supposed to help vulnerable patients—but without strong safeguards, it’s siphoning away funds that could be used for free and charitable medicine. The 340B Rebate Model Pilot improves program integrity, preventing duplicate discounts and strengthening accountability. Urge HHS to implement the pilot today. Learn why it matters.

Welcome to Punchbowl News AM! We're glad to have you here.

Want to get more of what you need? Share a bit more about yourself to help us tailor your reader experience.

Thank you for signing up!

Thank you for signing up!

 

We have sent you a confirmation email. Please follow the provided instructions to complete your sign-up.

Thank you for confirming! You are now subscribed to the Punchbowl News AM list.

You're subscribed! Welcome to the community.